|
DPAGT1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.496200E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.747400E-01 |
| Normal-vs-Stage2 |
4.026000E-01 |
| Normal-vs-Stage3 |
4.841400E-01 |
| Normal-vs-Stage4 |
7.327000E-01 |
| Stage1-vs-Stage2 |
3.060600E-01 |
| Stage1-vs-Stage3 |
4.133200E-01 |
| Stage1-vs-Stage4 |
7.932200E-01 |
| Stage2-vs-Stage3 |
8.367400E-01 |
| Stage2-vs-Stage4 |
4.429200E-01 |
| Stage3-vs-Stage4 |
5.316200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.378200E-01 |
| Normal-vs-AfricanAmerican |
4.407600E-01 |
| Normal-vs-Asian |
7.256800E-01 |
| Caucasian-vs-AfricanAmerican |
5.527200E-01 |
| Caucasian-vs-Asian |
7.409200E-01 |
| AfricanAmerican-vs-Asian |
6.042000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.575800E-01 |
| Normal-vs-Female |
2.024700E-03 |
| Male-vs-Female |
3.97939999999819E-05 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
6.717600E-01 |
| Normal-vs-Extreme_Weight |
2.909400E-01 |
| Normal-vs-Obese |
1.163790E-01 |
| Normal-vs-Extreme_Obese |
1.166610E-01 |
| Normal_Weight-vs-Extreme_Weight |
1.950420E-01 |
| Normal_Weight-vs-Obese |
3.841400E-01 |
| Normal_Weight-vs-Extreme_Obese |
2.184400E-01 |
| Extreme_Weight-vs-Obese |
1.025840E-02 |
| Extreme_Weight-vs-Extreme_Obese |
4.514000E-01 |
| Obese-vs-Extreme_Obese |
6.675600E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.212300E-02 |
| Normal-vs-Age(41-60Yrs) |
1.403020E-01 |
| Normal-vs-Age(61-80Yrs) |
5.342800E-01 |
| Normal-vs-Age(81-100Yrs) |
5.805400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.368020E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.174020E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.511900E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.982110E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.827240E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.424800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
9.870000E-01 |
| Normal-VS-Type2 PRCC |
9.619200E-01 |
| Normal-VS-KIRP CIMP |
8.978300E-02 |
| Normal-VS-Unclassified PRCC |
9.509800E-02 |
| Type1 PRCC-VS-Type2 PRCC |
9.672400E-01 |
| Type1 PRCC-VS-KIRP CIMP |
9.239200E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
4.126200E-02 |
| Type2 PRCC-VS-KIRP CIMP |
2.575800E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
9.092100E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
2.954000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.897200E-01 |
| Normal-vs-N1 |
4.359200E-01 |
| Normal-vs-N2 |
8.491200E-01 |
| N0-vs-N1 |
4.896800E-01 |
| N0-vs-N2 |
9.374800E-01 |
| N1-vs-N2 |
8.235000E-01 |
|
|
